Table 4.
Factors associated with numbers of PentixaFor+ sites, PentixaFor+ TBR, and numbers of CAP+ sites
N: PentixaFor+ sites | PentixaFor+ TBR | N: CAP+ sites | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Factor | Univariable | Multivariable | Univariable | Multivariable | Univariable | Multivariable | ||||||||||||||||
OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P | OR | 95% CI | P | |||||
Gender (male) | 1.39 | 0.90-2.11 | 0.13 | 1.01 | 0.87-1.17 | 0.87 | 1.81 | 1.12-2.86 | 0.01 | 1.56 | 1.36-1.78 | <0.01 | ||||||||||
Age | 1.01 | 0.99-1.02 | 0.31 | 1.00 | 0.99-1.01 | 0.92 | 1.06 | 1.04-1.08 | <0.01 | 1.03 | 1.02-1.04 | <0.01 | ||||||||||
Smoking | 1.22 | 0.81-1.85 | 0.34 | 1.07 | 0.93-1.24 | 0.32 | 1.64 | 1.05-2.57 | 0.03 | 1.27 | 1.14-1.43 | <0.01 | ||||||||||
Diabetes | 1.12 | 0.66-2.03 | 0.70 | 1.11 | 0.91-1.34 | 0.32 | 1.66 | 0.93-3.20 | 0.11 | |||||||||||||
Hyper-lipidemia | 1.45 | 0.92-2.37 | 0.12 | 1.16 | 0.99-1.36 | 0.08 | 1.50 | 0.90-2.61 | 0.13 | |||||||||||||
Hyper-tonus | 1.09 | 0.72-1.64 | 0.68 | 0.91 | 0.79-10.5 | 0.21 | 2.32 | 1.52-3.51 | <0.01 | 1.49 | 1.29-1.74 | <0.01 | ||||||||||
Previous CV event | 1.24 | 0.74-2.18 | 0.44 | 0.97 | 0.80-1.17 | 0.75 | 1.87 | 1.08-3.47 | 0.03 | 1.22 | 1.07-1.38 | <0.01 | ||||||||||
BMI | 1.08 | 1.02-1.14 | <0.01 | 1.00 | 0.98-1.02 | 1.00 | 1.03 | 1.02-1.05 | <0.01 | 1.01 | 1.00-1.03 | 0.11 | 1.00 | 0.95-1.07 | 0.88 | |||||||
Injected activity | 0.99 | 0.98-1.00 | 0.04 | 1.00 | 0.99-1.00 | <0.01 | 1.00 | 1.00-1.00 | 0.52 | 0.99 | 0.98-1.00 | 0.14 | ||||||||||
CoV | 1.07 | 1.05-1.10 | <0.01 | 1.06 | 1.06-1.07 | <0.01 | 1.02 | 1.01-1.03 | <0.01 | 1.02 | 1.01-1.03 | <0.01 | 1.00 | 0.97-1.04 | 0.80 | |||||||
TBR = target-to-background ratio, CAP = calcified atherosclerotic plaque, OR = Odds ratio, CI = confidence interval, BMI = body mass index, CoV = coefficient of variation; in bold are factors with significant associations in multivariable analyses.